Pharmacological evidence for opioid and adrenergic mechanisms controlling growth hormone, prolactin, pancreatic polypeptide, and catecholamine levels in humans
- 1 April 1985
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 34 (4), 383-390
- https://doi.org/10.1016/0026-0495(85)90229-x
Abstract
No abstract availableThis publication has 62 references indexed in Scilit:
- Suppression of prolactin and growth hormone responses to 2-deoxy-D-glucose-induced glucoprivation by mazindol in humansMetabolism, 1981
- Effects of Exogenous βh-Endorphin on Pituitary Hormone Secretionand Its Disappearance Rate in Normal Human Subjects*Journal of Clinical Endocrinology & Metabolism, 1981
- The endocrinology of the opiates and opioid peptidesMetabolism, 1981
- Prolactin response to beta-endorphin in manLife Sciences, 1980
- Inhibitory Effect of Guanfacine, a Central α-Adrenoceptor Agonist, on Prolactin Secretion Stimulated by Insulin-Induced HypoglycemiaJournal of Clinical Endocrinology & Metabolism, 1978
- New evidence for growth hormone modulation by the α-adrenergic system in manMetabolism, 1977
- STIMULATION IN VIVO OF THE SECRETION OF PROLACTIN AND GROWTH HORMONE BY β-ENDORPHINEndocrinology, 1977
- Effect of Clonidine on Growth Hormone, Prolactin, Luteinizing Hormone, Follicle-Stimulating Hormone, and Thyroid-Stimulating Hormone in the Serum of Normal MenJournal of Clinical Endocrinology & Metabolism, 1975
- Neuropharmacologic control of neuroendocrine function in manMetabolism, 1975
- Neural Regulation of Growth Hormone SecretionNew England Journal of Medicine, 1973